- Home
- BDTX vs GAN Comparison
BDTX vs GAN Comparison
Compare BDTX & GAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- GAN
- Stock Information
- Founded
- BDTX 2014
- GAN 1999
- Country
- BDTX United States
- GAN United States
- Employees
- BDTX N/A
- GAN N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- GAN Computer Software: Programming Data Processing
- Sector
- BDTX Health Care
- GAN Technology
- Exchange
- BDTX Nasdaq
- GAN Nasdaq
- Market Cap
- BDTX 96.9M
- GAN 81.1M
- IPO Year
- BDTX 2020
- GAN 2020
- Fundamental
- Price
- BDTX $1.61
- GAN $1.78
- Analyst Decision
- BDTX Strong Buy
- GAN
- Analyst Count
- BDTX 5
- GAN 0
- Target Price
- BDTX $15.60
- GAN N/A
- AVG Volume (30 Days)
- BDTX 8.2M
- GAN 205.3K
- Earning Date
- BDTX 03-06-2025
- GAN 03-14-2025
- Dividend Yield
- BDTX N/A
- GAN N/A
- EPS Growth
- BDTX N/A
- GAN N/A
- EPS
- BDTX N/A
- GAN N/A
- Revenue
- BDTX N/A
- GAN $134,998,000.00
- Revenue This Year
- BDTX N/A
- GAN $19.57
- Revenue Next Year
- BDTX N/A
- GAN $6.85
- P/E Ratio
- BDTX N/A
- GAN N/A
- Revenue Growth
- BDTX N/A
- GAN 4.31
- 52 Week Low
- BDTX $1.55
- GAN $1.17
- 52 Week High
- BDTX $7.66
- GAN $1.90
- Technical
- Relative Strength Index (RSI)
- BDTX 38.60
- GAN 49.63
- Support Level
- BDTX $1.55
- GAN $1.76
- Resistance Level
- BDTX $1.84
- GAN $1.81
- Average True Range (ATR)
- BDTX 0.23
- GAN 0.03
- MACD
- BDTX 0.01
- GAN 0.00
- Stochastic Oscillator
- BDTX 5.26
- GAN 50.00
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About GAN GAN Limited
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.